REFERENCES
- Tai B, Straus MM, Liu D, Sparenborg S, Jackson R, McCarty D. The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment. J Subst Abuse Treat 2010; 38(Suppl. 1):S4–S13.
- Wells EA, Saxon AJ, Calsyn DA, Jackson TR, Donovan DM. Study results from the Clinical Trials Network’s first 10 years: Where do they lead? J Subst Abuse Treat 2010; 38(Suppl. 1):S14–S30.
- Nunes EV, Ball S, Booth R, Brigham G, Calsyn DA, Carroll K, Feaster DJ, Hien D, Hubbard RL, Ling W, Petry NM, Rotrosen J, Selzer J, Stitzer M, Tross S, Wakim P, Winhusen T, Woody G. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs? J Subst Abuse Treat 2010; 38(Suppl. 1):S97–S112.
- National Drug Abuse Treatment – Clinical Trials Network – Dissemination Library. Available at http://ctndisseminationlibrary.org/. Last accessed on June 28, 2011.
- Brigham GS, Feaster DJ, Wakim PG, Dempsey CL. Choosing a control group in effectiveness trials of behavioral drug abuse treatments. J Subst Abuse Treat 2009; 37:388–397.
- Center for Information & Study on Clinical Research Participation. Clinical Trial Facts & Figures. Available at http://www.ciscrp.org/professional/facts_pat.html. Last accessed on July 22, 2010.
- Treweek S, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, Johansen M, Sullivan F, Wilson S, Jackson C, Jones R, Mitchell E. Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev 2010; 4:MR000013.
- Potter JS, Donovan D, Weiss RD, Gardin J, Lindblad B, Wakim P, Dodd D. Site selection in community-based clinical trials for substance use disorders: Strategies to enhance successful implementation. Am J Drug Alcohol Abuse 2011.
- Magruder KM, Ouyang B, Miller S, Tilley BC. Retention of under-represented minorities in drug abuse treatment studies. Clin Trials 2009; 6:252–260.
- Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Sharpe Potter J, Forman R, Vetter V, McNicholas L, Blaine J, Lynch KG, Fudala P. Extended vs. short-term buprenorphine-naloxone for treatment of opioid-addicted youth. J Am Med Assoc 2008; 300(17):2003–2011.
- Getz KA, Wenger J, Campo RA, Seguine ES, Kaitin KI. Assessing the impact of protocol design changes on clinical trial performance. Am J Ther 2008; 15:450–457.
- Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend 2006; 81:267–274.
- Fals-Stewart W, Lam WKK. Computer-assisted cognitive rehabilitation for the treatment of patients with substance use disorders: A randomized clinical trial. Exp Clin Psychopharmacol 2010; 18:87–98.
- Heinzerling KG, Swanson A, Kim S, Cederblom L, Moe A, Ling W, Shoptaw S. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend 2010; 109:20–29.